The Potential Use of HIV Vaccines for the Treatment of HIV Infection: Scientific Summary of the State-of-the-Art

THE POTENTIAL USE OF HIV VACCINES FOR THE TREATMENT OF HIV INFECTION
SCIENTIFIC SUMMARY OF THE STATE-OF-THE-ART
Table of Contents
I. Introduction
II. What is the Scope of the NIH Effort in HIV Vaccines?
III. Current Status of HIV Vaccine Research - Prophylactic HIV Vaccine
Candidates
What have we Learned to Date from Clinical Trials of Prophylactic
HIV Vaccines Candidates?
The NIAID Prophylactic HIV Vaccine Research and Development Agenda
IV. Current Status of HIV Vaccine Research - HIV Therapeutic Vaccine
Candidates
Phase I: NIH-Sponsored or Jointly Sponsored Therapeutic Vaccine

Phase I:
Phase II:
Phase II:
Pediatric

Trials
Non-NIH Sponsored Therapeutic Vaccine Candidate Trials
NIH-Co-Sponsored Therapeutic Vaccine Candidate Trials
Non-NIH Sponsored Therapeutic Vaccine Candidate Trials
Therapeutic Vaccine Research

VI. Scientific Criteria for Phase III Therapeutic Vaccine Efficacy Trials
VI. Summary of Current Data on Therapeutic Vaccines
VII. Summary of Status of Vaccines for Prophylaxis and for Treatment of HIV
Infection
IIX. Tables